PMEPA1 and Familial prostate cancer: Lower PMEPA1-b expression and a higher ratio of PMEPA1-a versus PMEPA-b were all correlated to higher Gleason scores and lower progression free survival rate in the cohort composing of 499 prostate cancer patients [11].